What is Amylyx Pharmaceuticals, Inc.'s net change in cash?

Amylyx Pharmaceuticals, Inc. (AMLX) reported net change in cash of $2.49M in Q1 2026.

How has Amylyx Pharmaceuticals, Inc.'s net change in cash changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s net change in cash increased by 114.1% year-over-year, from -$17.62M to $2.49M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Amylyx Pharmaceuticals, Inc. AMLX Net Change in Cash

Net Change in Cash at other companies

MBX Biosciences, Inc.MBX

-$29.87M-53.6%

Viking TherapeuticsVKTX

-$47.71M-524%

Beam TherapeuticsBEAM

-$6.64M-103%

Crinetics PharmaceuticalsCRNX

$12.81M+108%

Agios PharmaceuticalsAGIO

$24.47M+801%

Rhythm Pharmaceuticals, Inc.RYTM

$7.92M-53.3%

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.82B+390%

Enterprise value$1.6B+414%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s net change in cash?: Amylyx Pharmaceuticals, Inc. (AMLX) reported net change in cash of $2.49M in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s net change in cash changed year-over-year?: Amylyx Pharmaceuticals, Inc.'s net change in cash increased by 114.1% year-over-year, from -$17.62M to $2.49M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.